Best Growth Stocks to Buy for August 28th

Zacks highlights three Zacks Rank #1 (Strong Buy) names—CarGurus, Audioeye, and Charles River Associates—citing upward revisions to current-year earnings estimates of +11.7%, +27.0%, and +12.0%, respectively, over the last 60 days. Valuation/growth metrics are also favorable (e.g., CarGurus PEG 1.01 vs. industry 1.08; CRAI PEG 1.48 vs. 1.84; Audioeye PEG 2.06 vs. 21.04), suggesting strong growth characteristics. Overall, the piece is constructive but framed as stock-selection/research commentary rather than a specific fundamental catalyst.

Analysis

This screen is more a factor check than a true catalyst: estimate revisions and PEG support can keep these names bid, but only if the next print confirms real operating acceleration. The best risk/reward is probably CARG because marketplace revenue is directly levered to dealer marketing budgets and unit throughput; if rates drift lower and used-car activity stabilizes, take-rate and ad demand can improve together. The flip side is fast deterioration if dealers pull spend first in any affordability scare, which would hit CARG before the broader auto complex.

AEYE is the cleanest structural story because accessibility spend is compliance-driven and less tied to GDP, but the market will punish any sign that growth is coming from a small number of wins or one-time conversions. CRAI looks like the most durable compounding name: advisory demand tied to disputes, regulatory work, and transaction complexity tends to hold up when the cycle is mixed, though the growth premium can compress if dealmaking or litigation intensity fades. AGRO appears to be a feed-quality issue rather than a genuine signal, so I would not anchor on it.

Contrarian view: this is a crowded, backward-looking screen. PEG ratios and revision momentum often overstate quality in small caps because estimates are noisy and easily revised after management guidance. The real falsifier is the next earnings call: if CARG does not show revenue acceleration, AEYE does not show retention/booking durability, or CRAI softens on forward demand, the multiple support from this article disappears quickly.

Key Decisions for Investors

• Long CARG on a 1-3 month horizon only if the stock pulls back 5-8% from current levels; pair it against CARS for a relative-value expression. Thesis breaks if dealer ad-spend commentary weakens or next-quarter revenue growth decelerates.
• Small starter long AEYE for 2-3 months as a compliance-led growth name, but keep sizing modest given small-cap execution risk. Add only if next report confirms bookings/retention strength; cut if ARR or billings decelerate.
• Long CRAI into any market-volatility-driven weakness over the next 1-3 months; it should be the most resilient of the group if corporate disputes and regulatory work stay active. Consider a CRAI/FTI relative long-short if you want to isolate the consulting quality factor.
• Do not trade AGRO from this note until the data error is cleaned up; no reliable thesis can be built from the current feed.